Examination of Witness (Questions 20-39)
MALCOLM WICKS
MP
21 MARCH 2007
Q20 Dr Iddon: What other engagement
do you have with the DfES to persuade students to go on beyond
ordinary level sciences into A level sciences and, hence, hopefully
on to university?
Malcolm Wicks: There is quite
a lot of engagement. Although I used to be, I am not going to
pretend to be an education minister, as it were, because I am
not one, but we are very heavily engaged. I have mentioned the
discussions I have at ministerial level and my officials are engaged.
Clearly, from our departmental point of view, given the importance
of building a knowledge economy, which in many respects needs
to be a science-based economy, we need good numbers, and I would
like to see rising numbers of people going on to do the A levels
and the university degrees, postgraduate, et cetera. That is our
scientific and economic interest in this. We are very heavily
engaged. We are also very heavily engaged, for example, in what
I think could be a very important development, that of establishing
science and engineering clubs. We launched those clubs during
science week, which we have just come to the conclusion of. I
went to Seven Kings School in Ilford, Essex, to launch that and
Bill Rammell was in York. If we could get such clubs involved
in more schools, if scientists and engineers from industry and
the public sector could get involved in those clubs. We have a
very good ambassador scheme, as you know, already. Science ambassadors,
often quite young people in the public sector, in industry, are
giving up some of their time, often with enthusiastic backing
from the likes of Rolls Royce. If we can get those things going,
then I think we stand a very good chance of engaging more young
people in this enterprise.
Q21 Mr Newmark: You have talked about
the knowledge economy, as has the Chancellor, yet the perception
out there for those at the sharp endand there was a report
by the House of Lords Science and Technology Committee published
last year on science and teaching in schoolsis of a problem
with funding for the maintenance and improvement of school science
laboratories. I am wondering what the Government is doing just
to deal with that very basic need in schools.
Malcolm Wicks: I am surprised
to hear you report that.
Q22 Mr Newmark: I am only reflecting
what was in the House of Lords Science and Technology Committee
report of November 2006.
Malcolm Wicks: Their Lordships,
I am sure, will know that we are now engaged in a very major school
building programme and improvement programme which is going to
touch every secondary school in the country over time. That will
enable us to build new laboratories fit for purpose. I think we
are already seeing but we will see in the future huge improvements
in laboratory facilities in schools.
Q23 Mr Newmark: You are talking about
new schools. Are you talking about retro-fitting laboratories
in existing schools as well?
Malcolm Wicks: There is an improvement
programme as well, yes. I think the figures are available. When
we talk about school building programmes, we are not just talking
about 5% or something over 20 years. This is a colossal investment
of funding to rebuild many of our secondary schools.
Q24 Mr Newmark: I understand that,
but I asked you a very specific question to do with sciences and
funding laboratories and so on. So there will be more than adequate
fundingbecause you have used this phrase "adequate
funding".
Malcolm Wicks: Just as my department
has enabled the universities to have huge numbers of new laboratorieswhich
is one of the great achievements of this Labour Government of
which I am sure we are both proudto bring about
Q25 Mr Newmark: I am sure the chemistry
department at Exeter and other universities that are shutting
down would not say that.
Malcolm Wicks: I know, but look
at this more objectively and you will see major new investment
in laboratories and universities and, in parallel with that, we
are seeing similar developments over coming years in our schools.
Q26 Mr Newmark: Once the students
have had their degrees and so on or their A levels, what steps
are the Government taking to improve the quality of careers advice
relating to STEM subjects?
Malcolm Wicks: I think careers
advice, as ever, remains a very live subject. There is a lot of
excellent careers advice being given by the Connexions service,
for example. One of the things we need to do is not just to focus
on the career service or Connexions but also we need to enable
more teachers themselves to have direct experience of modern day
science. We often talk about work experience for pupils and I
think we also need to focus on, if you like, work experience for
teachers, so more teachers can go into high-tech, bio-science
facilities and gain an improved understanding of what science
careers and related engineering technology have to offer children.
Q27 Mr Newmark: On that subject,
there is a shortage of specialist physics and chemistry teachers.
Do you think this will stimulate more people to take up teaching
careers in chemistry, physics and so on?
Malcolm Wicks: I hope so. There
are of course facilities so that a science teacher of, say, biology
can study physics, to come up to scratch, as it were, on that.
There are the "golden hello" awards to try to attract
scientists into teaching. Quite a good deal has been done.
Q28 Mr Newmark: Why is there this
challenge that we are facing at the moment? We have this great
aspiration from all parties. We recognise there is a huge challenge
out there with what is going on in India and in China with the
huge numbers of science graduates coming out. We see this challenge,
this competitive risk to our economy, our excellence in science
and so on, yet there is this shortage of teachers willing to go
in and teach subjects such as physics and chemistry, and a declining
interest, it looks like, in students wanting to go into the sciences.
How are we dealing with this challenge? It is a big problem.
Malcolm Wicks: It is a big problem.
I have mentioned the "golden hello" programme.
Q29 Mr Newmark: You need more than
a "golden hello". That is just a cash thing. There needs
to be something else out there.
Malcolm Wicks: Cash is not unimportant.
When it comes to those studying, say, at A level one needs to
look at the data rather carefully. In certain subjects, I think
the student numbers are holding their own or even maybeand
it depends where you compareslightly increasing. In some
areas we do have some serious problems, like physics, where there
has been a decline since 1997, if I am reading the data correctlywhich
I am, in terms of the numbers doing physics. I do not think any
of us can be complacent about these things. Getting physicists
into teaching and finding ways of doing that, which the Department
of Education are seeking to do, is crucial to this. Of course
it is.
Q30 Chairman: I know it is sometimes
unfair to ask you questions which are
Malcolm Wicks: But it will not
stop you, Chairman, I know.
Q31 Chairman: No, I try to be generous
and helpful.
Malcolm Wicks: Yes, I know.
Q32 Chairman: I accept that this
particular line of questioning is very much the DfES's frontline
responsibility, but would it be possible for you or your officials
to drop us a note outlining where you are connecting; where there
is some joined-up government between your department and the DfES
in terms of these core issues of how we develop good science in
our schools; how we make sure the issues which Brian has raised
of 21st Century Science gets a proper airing; and where the connections
are between your ministry and the DfES. Perhaps you could let
us have a note on that.
Malcolm Wicks: I think that would
be very helpful, because we could tell you about the strategy
group on STEM, in which my department and DfES are involved, and
about the meetings I am having with Bill Rammell and colleagues.
Q33 Chairman: It would be useful
to get that on the record. Could we move on, then, to Cooksey
and the Cooksey Review. What discussions has OSI had concerning
the implementation of Sir David Cooksey's recommendations for
UK health research reforms?
Malcolm Wicks: There is a lot
of work going on. We are heavily involved in that. Keith O'Nions
sits on the interim oversight group, which has been established
by John Bell to assist this development in advance of the OSCHR
board being created. So there is a great deal of work going on,
not least to develop the joint CSR bid for the establishment of
OSCHR itself.
Q34 Chairman: Could I turn to something
which concerned us when we met Sir David Cooksey about the role
of OSCHR. How has OSI worked with OSCHR in terms of putting together
this spending review, particularly in relation to the MRC funded
research? It seemed to be quite clear in terms of what was happening
with the NHS clinical research funding, but what is happening
in terms of the relations between OSI and OSCHR, which traditionally
would have been your responsibility?
Malcolm Wicks: Yes. There is a
lot of work going on at official level. The details and the structure
of OSCHR itself are still being discussed. I believe you are about
to publish a report on this, is that right?
Q35 Chairman: We are, yes. Tomorrow.
Malcolm Wicks: We will respond
to that in due course.
Q36 Dr Harris: Could I correct that.
We published a report on Cooksey last week. It is a different
report we are publishing tomorrow on Research Councils.
Malcolm Wicks: The details and
structure of OSCHR are still being discussed. As you know, we
see this as a rather light-touch organisation, somewhere between
only five to ten staff, jointly funded by the department and the
Department of Health. Obviously we have a great deal of interest
in MRC. It is one of our Research Councils. We see MRC as essentially
retaining the same institutional structure as it now has. I just
want to emphasise, if it needs emphasising, that, just as the
review itself recognised, we certainly recognise the sheer importance
of basic research, which is very much the hallmark of the MRC,
but of course we remain very committed to the idea of a better
alignment between the work of the MRC and health research within
the healthcare system.
Q37 Dr Harris: The OSI are the sponsoring
department for the pharmaceutical industry and Cooksey made a
number of recommendations about trying to speed up the drug pipeline.
Some people interpret his report as suggesting that we should
use MRC and NAIHR funds to add structures to help the pipeline
along in certain areas. As far as you know, are you aware whether
the DTI has responded to the Cooksey Report and Review supporting
those proposals or are they still being discussed?
Malcolm Wicks: We are committed
to that principle you have outlined for all sorts of obvious reasons.
One is that it could enhance healthcare and patient care. That
is the main reason. We are very good at pharmaceuticals; we need
to maintain our international position. We are very good at bioscience
and we need to maintain that. I do think we now have a great opportunity,
not least through the connecting for health proposals, to improve
the situation further in Great Britain. If we can get a better
alignment between pure research, applied research in the National
Health Service, the capacity for clinical trials and so on, with
connecting for health, I think we can really see a step-change
in the future.
Q38 Dr Harris: Could I put another
view to you and ask you for your reaction. Some people feel it
is not really the job of the MRC and the NAIHR to fill in gaps
and help the pipeline along, partly because it distorts the priorities
away from public health research which does not involve drugs
and, indeed, other forms of health intervention which again do
not involve drugs, and so maybe it is best left to pharma to do
pharma and for public sector medical research, including pharmaceuticals,
to do what it thinks is necessary rather than being pushed towards
helping drug development.
Malcolm Wicks: I am sorry, I do
not see this whole development of involving that "push"
as you put it. There are certain basic principles about the importance
of what some people call "basic research". Even more
important are principles about healthcare. How do we improve the
healthcare of the nation? They are the crucial things. As you
have reminded us (if we need reminding) that does not just include
drugs and pharmaceutical companies. I do not see that potential
distortion to which I think you are alluding, but I do think if
we can have serious discussions about how we can enhance bioscience,
how we can make sure Britain remains a good place for pharmaceuticals
but with a better alignment with the National Health Service,
that would be in the interests of patient care. But this is not
just going to be driven by any one industry. Of course it is not.
Q39 Graham Stringer: There is a feeling,
Minster, as research is streamlined and better directed, that
there is over-influence of the golden triangle between Oxford,
Cambridge and London, and that there is an unfairness of the spatial
distribution of research when it comes to the consideration of,
for example, Newcastle, Manchesterbasically the hospitals
and universities outside that triangle. Are you aware of that?
Do you think that feeling has substance? I am thinking particularly
about the decision on the biomedical research facility in Manchester
recentlyor not in Manchester, as it turns out.
Malcolm Wicks: I would certainly
like to see more clusters of excellence. The golden triangle in
this part of the world is a fact of life and I think is delivering
many benefits.
|